Hepatobiliary and Pancreatic Diseases: Novel Strategies of Diagnosis and Treatments

Dear Colleagues,

Disease of the liver and pancreas plays a significant role in the clinical, surgical, and research activity of the medical community.

Hepatitis or pancreatitis, even if benign, can put patients at risk of life as well as pose important limitations on their quality of life. Therefore, increasingly advanced medical and/or surgical treatments are required to improve the treatment of these pathologies.

Malignant tumors of the liver and pancreas represent an increasingly growing entity in our society. The incidence of pancreatic cancer has now reached a position in the top ten of the most common cancers in the world. Malignant tumors of the liver and biliary tract, fortunately, still maintain a lower incidence, albeit increasing, and are not among the most frequent malignant tumors in the general population. However, malignant tumors of the liver, biliary tract, and pancreas are gaining significance in terms of annual mortality rates.

The increase in research activity and the subsequent clinical application appears to be the only weapon available to be able to deal with cancers with such devastating results.

We therefore invite all colleagues to send us their most promising medical and surgical research in the field of HPB pathologies to make an important scientific contribution in this field.

Dr. Alessandro Coppola
Dr. Damiano Caputo
Dr. Roberta Angelico
Dr. Domenech Asbun
Dr. Chiara Mazzarelli
Topic Editors